Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

MaxDiscovery™ Human IL-29 ELISA Test Kit

Product Description
The MaxDiscovery™ Human IL-29 ELISA Test Kit is designed for quantitative determination of the concentration of human IL-29 in serum, plasma, and cell culture supernatant. Human interleukin 29 (IL-29) is a cytokine distantly related to type I interferons and the IL-10 family. IL-29, interleukin 28A (IL-28A) and interleukin 28B (IL-28B), known as IFN?1, ?2, and ?3, are three closely related cytokine genes that form a cytokine gene cluster on chromosome 19. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor beta (IL-10Rß) and interleukin 28 receptor alpha (IL-28Ra). IFN?s are a novel family of interferons which mediate the induction of antiviral protection in a wide variety of cells. IFN?s share with type I IFNs an intracellular signaling pathway that drives the expression of a common set of IFN stimulated genes. IFN?s induce multiple biological activities, including the upregulation of class I MHC gene product expression to levels comparable to those induced by IFNa. Consistent with a role in antiviral protection, the mRNA expression of IFN? is detectable in cells infected with various viruses. Furthermore, monocytederived dendritic cells (important producers of IFNa) express IFN?1mRNA in response to treatment with dsRNA. TLR3 and TLR4 ligands induce IFNa, IFNß, IL-28, and IL-29 gene expression in macrophages. This is dependent upon IFNa. IFN? mediates its antiviral protection through a class II cytokine receptor complex distinct from that of type I IFNs. This is comprised of two essential receptor proteins, CRF212/IFN?R1, which is unique to IFN?, and CFR24/IL10R2, which is shared with IL10, IL22, and IL26 receptors. Whereas, the two chains of the type I IFN receptor (IFNAR1 and IFNAR2) and IL10R2 are ubiquitously expressed, IFN?R1 expression is limited and celltype dependent. IFN?R1 is not expressed by monocytes, but is upregulated during GMCSF/ IL4 induced differentiation of DCs from human monocytes, yielding iDCs which are fully responsive to IFN?. The IFN?s, IL28 and IL29, have recently been reported to prime dendritic cells to induce proliferation of Foxp3 bearing regulatory T cells. IFN? matured DCs express high levels of class I and II MHC gene products, but low levels of costimulatory molecules, and are able to specifically induce IL-2dependent proliferation of CD4+CD25+FOXP3+ T cell population with contact dependent suppressive activity on T cells.
Product MaxDiscovery™ Human IL-29 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2128-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos